EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
Diagnosis of prostate cancer
JL Descotes - Asian journal of urology, 2019 - Elsevier
Diagnosis of prostate cancer (PCa) and adequate staging play a fundamental role for
clinical and patient care. Despite major advances in biology and imaging, rectal examination …
clinical and patient care. Despite major advances in biology and imaging, rectal examination …
E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET
Rationale The development of consensus guidelines for interpretation of Prostate-Specific
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …
risk stratification and workup, treatment options for localized disease, and management of …
[HTML][HTML] Prostate-specific membrane antigen radioguided surgery to detect nodal metastases in primary prostate cancer patients undergoing robot-assisted radical …
Background Extended pelvic nodal dissection (ePLND) represents the gold standard for
nodal staging in prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) …
nodal staging in prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) …
Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly …
Context The role of positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA) in the primary staging for patients with prostate …
prostate-specific membrane antigen (PSMA) in the primary staging for patients with prostate …
Using PSMA imaging for prognostication in localized and advanced prostate cancer
MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …
prostate cancer management has evolved rapidly over the past few years, helping to …
The key combined value of multiparametric magnetic resonance imaging, and magnetic resonance imaging–targeted and concomitant systematic biopsies for the …
Background The combined role of multiparametric magnetic resonance imaging (mp-MRI),
and magnetic resonance imaging (MRI)-targeted and concomitant systematic biopsies in the …
and magnetic resonance imaging (MRI)-targeted and concomitant systematic biopsies in the …
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab
T Kobayashi, K Ito, T Kojima, M Kato, S Kanda… - Cancer …, 2021 - Wiley Online Library
The use of immune checkpoint inhibitors to treat urothelial carcinoma (UC) is increasing
rapidly without clear guidance for validated risk stratification. This multicenter retrospective …
rapidly without clear guidance for validated risk stratification. This multicenter retrospective …
[HTML][HTML] External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the …
Background Different nomograms exist for the preoperative prediction of pelvic lymph-node
metastatic disease in individual patients with prostate cancer (PCa). These nomograms do …
metastatic disease in individual patients with prostate cancer (PCa). These nomograms do …